IMmotion151研究最終OS結果出爐( 二 )

】RobertJ.Motzer,ThomasPowlesetal.FinalOverallSurvivalandMolecularAnalysisinIMmotion151,aPhase3TrialComparingAtezolizumabPlusBevacizumabvsSunitinibinPatientsWithPreviouslyUntreatedMetastaticRenalCellCarcinoma.JAMAOncol.doi:10.1001/jamaoncol.2021.5981PublishedonlineDecember23,2021